Benefits of alpine mountain climate of bavaria in patients with allergic diseases and chronic obstructive pulmonary disease: Results from the AURA* study

Journal of Investigational Allergology and Clinical Immunology

Volumn 19, Issue 2, 2009, Pages 159-161

  Eberlein, B ^a,b   Gulyas, A ^c   Schultz, K ^d   Lecheler, J ^d   Flogel S ^c   Wolfmeyer, C ^d   Thiessen, K ^d   Gass, S ^d   Kroiss, M ^d   Huss Marp, J ^a   Darsow, U ^a,b   Hollweck, R ^e   Schuster, T ^e   Behrendt, H ^a,b   Ring, J ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Klinik Santa Maria   (Germany)

^d Fachklinik Allgäu ^*  (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Asthma; Atopiceczema; Climatetherapy; COPD

Indexed keywords

ADULT; ALLERGIC ASTHMA; ARTICLE; ATOPIC DERMATITIS; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLIMATOTHERAPY; CLINICAL TRIAL; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; GEOGRAPHY; GERMANY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PROVOCATION TEST; QUESTIONNAIRE; SKIN FUNCTION; TREATMENT DURATION;

ADULT; ASTHMA; BRONCHIAL PROVOCATION TESTS; CHEMOKINE CCL17; CHILD; CLIMATOTHERAPY; DERMATITIS, ATOPIC; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; EXERCISE TEST; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-16; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SKIN TESTS;

EID: 65249083987     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Engst R, Vocks E. High-mountain climate therapy for skin diseases and allergy: Mode of action, therapeutic results, and immunologic effects. Rehabilitation. 2000;39:215-22.
2. Schultze-Werninghaus G. Should asthma management include sojourns at high altitude? Chem Immunol Allergy. 2006;91:16-29.
3. Kunz B, Oranje AP, Labréze L, Stalder JF, Ring J, Taïeb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195:10-19.
4. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13:595-605.
5. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self- complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321-7.
6. Schäfer T, Staudt A, Ring J. German instrument for the assessment of quality of life in skin diseases (DIELH). Internal consistency, reliability, convergent and discriminant validity and responsiveness. Hautarzt. 2001;52:624-8.
7. Ware JJ, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey. Manual and interpretation guide. Boston, The Health Institute, New England Medical Center, 1993.
8. Darsow U, Mautner VF, Bromm B, Scharein E, Ring J. The Eppendorf Pruritus Questionnaire. Hautarzt. 1997;48:730-3.
9. Ravens-Sieberer U, Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res. 1998;7:399-407.
10. Eberlein B, Gulyas A, Schultz K, Lecheler J, Flögel S, Wolfmeyer C, Thiessen K, Jakob T, Schuster T, Hollweck R, Ring J, Behrendt H. Domestic allergens and endotoxin in three hospitals offering in-patient rehabilitation for allergic diseases in the alpine mountain climate of Bavaria - the AURA study. Int J Hyg Environ Health. 2009; 212: 21-26.